Condition: Tumor Recurrence · Malignant Epithelial Neoplasm of Vulva · Malignant Epithelial Tumor of Ovary · Sponsor: CNAO National Center of Oncological Hadrontherapy
The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).
This description comes directly from the study's public registry record.
Amelia Barcellini, MD · 390382075501 · amelia.barcellini@cnao.it
Cristina Bono, MSc · 390382075613 · cristina.bono@cnao.it
Always discuss trial participation with your own doctor first.
| CNAO | Pavia, Pv, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05457595